Saturday 17 October 2026
Export OKYO’s income statement to Excel — free account
OKYO Pharma Limited Sponsored ADR
OKYO Healthcare Biotechnology
Insiders bought in the last twelve months.
1.41
0.02
−1.40%
Follow OKYO
| Mar '26 | Sep '25 | Mar '25 | Sep '24 | Older periods | |
|---|---|---|---|---|---|
| 0.00% | 0.00% | 0.00% | 0.00% |
+7 more TTM periods Free account |
|
| 0.00% | 0.00% | 0.00% | 0.00% | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow |
(9.53) | (13.07) | (19.25) | (20.85) | |
Capital Expenditures |
(0.01) | — | (0.01) | — | |
| Other line items | |||||
Cash ROIC |
(28.94%) | (1,319.14%) | 482.53% | 334.24% | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.00 | 0.00 | 0.00 | 0.00 | |
Depreciation/Fixed assets |
0.43 | 7.17 | 1.10 | 4.77 | |
Capex/Depreciation |
(2.03) | 0.00 | (0.87) | 0.00 | |
Operating CF per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex per Share |
0.00 | — | 0.00 | — | |
Capex to Sales |
0.00 | — | 0.00 | — |
Columns are period end dates